{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:06:23Z","timestamp":1794744383060,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tau pathology in Alzheimer\u2019s disease (AD) spreads in a predictable pattern that corresponds with disease symptoms and severity. At post-mortem there are cortical regions that range from mildly to severely affected by tau pathology and neuronal loss. A comparison of the molecular signatures of these differentially affected areas within cases and between cases and controls may allow the temporal modelling of disease progression. Here we used RNA sequencing to explore differential gene expression in the mildly affected primary visual cortex and moderately affected precuneus of ten age-, gender- and RNA quality-matched post-mortem brains from AD patients and healthy controls. The two regions in AD cases had similar transcriptomic signatures but there were broader abnormalities in the precuneus consistent with the greater tau load. Both regions were characterised by upregulation of immune-related genes such as those encoding triggering receptor expressed on myeloid cells 2 and membrane spanning 4-domains A6A and milder changes in insulin\/IGF1 signalling. The precuneus in AD was also characterised by changes in vesicle secretion and downregulation of the interneuronal subtype marker, somatostatin. The \u2018early\u2019 AD transcriptome is characterised by perturbations in synaptic vesicle secretion on a background of neuroimmune dysfunction. In particular, the synaptic deficits that characterise AD may begin with the somatostatin division of inhibitory neurotransmission.<\/jats:p>","DOI":"10.1038\/s41598-021-83872-z","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T11:07:32Z","timestamp":1614596852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Defining early changes in Alzheimer\u2019s disease from RNA sequencing of brain regions differentially affected by pathology"],"prefix":"10.1038","volume":"11","author":[{"given":"Boris","family":"Guennewig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"McCorkindale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Paasila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian J.","family":"Kril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg T.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"83872_CR1","unstructured":"Access Economics. Keeping Dementia Front of Mind: Incidence and Prevalence 2009 \u20132050. Report for Alzheimer's Australia. (Canberra, 2009)"},{"key":"83872_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","volume":"7","author":"CR Jack Jr","year":"2011","unstructured":"Jack, C. R. Jr. et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 257\u2013262. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.004 (2011).","journal-title":"Alzheimers Dement."},{"key":"83872_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine, T. J. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach. Acta Neuropathol. 123, 1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3 (2012).","journal-title":"Acta Neuropathol."},{"key":"83872_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics. Science 297, 353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994 (2002).","journal-title":"Science"},{"key":"83872_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois, B. et al. Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 12, 292\u2013323. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.002 (2016).","journal-title":"Alzheimers Dement."},{"key":"83872_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon, B. A. et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: A longitudinal study. Lancet Neurol. 17, 241\u2013250. https:\/\/doi.org\/10.1016\/S1474-4422(18)30028-0 (2018).","journal-title":"Lancet Neurol."},{"key":"83872_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen, E. et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes?. J. Alzheimers Dis. 7, 63\u201380 (2005).","journal-title":"J. Alzheimers Dis."},{"key":"83872_CR8","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","volume":"24","author":"SM de la Monte","year":"2014","unstructured":"de la Monte, S. M. Type 3 diabetes is sporadic Alzheimers disease: Mini-review. Eur. Neuropsychopharmacol. 24, 1954\u20131960. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.06.008 (2014).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"83872_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785\u2013789. https:\/\/doi.org\/10.1038\/378785a0 (1995).","journal-title":"Nature"},{"key":"83872_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal, D. R., Rub, U., Orantes, M. & Braak, H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791\u20131800 (2002).","journal-title":"Neurology"},{"key":"83872_CR11","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1, a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"83872_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol. (Berl)"},{"key":"83872_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0306-4522(01)00169-5","volume":"105","author":"TC Dickson","year":"2001","unstructured":"Dickson, T. C. & Vickers, J. C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease. Neuroscience 105, 99\u2013107 (2001).","journal-title":"Neuroscience"},{"key":"83872_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-016-0275-x","volume":"4","author":"SB Wharton","year":"2016","unstructured":"Wharton, S. B. et al. Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study. Acta Neuropathol. Commun. 4, 11. https:\/\/doi.org\/10.1186\/s40478-016-0275-x (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"83872_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. & Hyman, B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019 disease. Neurology 42, 631\u2013639 (1992).","journal-title":"Neurology"},{"key":"83872_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JAD-2011-110026","volume":"25","author":"GT Sutherland","year":"2011","unstructured":"Sutherland, G. T., Siebert, G. A., Kril, J. J. & Mellick, G. D. Knowing me, knowing you: Can a knowledge of risk factors for Alzheimer\u2019s disease prove useful in understanding the pathogenesis of Parkinson\u2019s disease?. J. Alzheimers Dis. 25, 395\u2013415. https:\/\/doi.org\/10.3233\/JAD-2011-110026 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"83872_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2010.03.110","volume":"1338","author":"IA Qureshi","year":"2010","unstructured":"Qureshi, I. A., Mattick, J. S. & Mehler, M. F. Long non-coding RNAs in nervous system function and disease. Brain Res. 1338, 20\u201335. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.110 (2010).","journal-title":"Brain Res."},{"key":"83872_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2016.05.007","author":"KE Hargis","year":"2016","unstructured":"Hargis, K. E. & Blalock, E. M. Transcriptional signatures of brain aging and Alzheimer\u2019s disease: What are our rodent models telling us?. Behav. Brain Res. https:\/\/doi.org\/10.1016\/j.bbr.2016.05.007 (2016).","journal-title":"Behav. Brain Res."},{"key":"83872_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.12.015","author":"B Bai","year":"2020","unstructured":"Bai, B. et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2019.12.015 (2020).","journal-title":"Neuron"},{"key":"83872_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0197-4580(02)00227-0","volume":"24","author":"GM Halliday","year":"2003","unstructured":"Halliday, G. M., Double, K. L., Macdonald, V. & Kril, J. J. Identifying severely atrophic cortical subregions in Alzheimer\u2019s disease. Neurobiol. Aging 24, 797\u2013806 (2003).","journal-title":"Neurobiol. Aging"},{"key":"83872_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1471-4159.2010.07157.x","volume":"116","author":"GT Sutherland","year":"2011","unstructured":"Sutherland, G. T., Janitz, M. & Kril, J. J. Understanding the pathogenesis of Alzheimer\u2019s disease: Will RNA-Seq realize the promise of transcriptomics?. J. Neurochem. 116, 937\u2013946. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07157.x (2011).","journal-title":"J. Neurochem."},{"key":"83872_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bcp.2018.09.027","volume":"158","author":"K Mullane","year":"2018","unstructured":"Mullane, K. & Williams, M. Alzheimer\u2019s disease (AD) therapeutics\u20142: Beyond amyloid\u2014Re-defining AD and its causality to discover effective therapeutics. Biochem. Pharmacol. 158, 376\u2013401. https:\/\/doi.org\/10.1016\/j.bcp.2018.09.027 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"83872_CR23","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1007\/s11033-014-3516-8","volume":"41","author":"JD Mills","year":"2014","unstructured":"Mills, J. D. et al. The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer\u2019s disease patients. Mol. Biol. Rep. 41, 6365\u20136376. https:\/\/doi.org\/10.1007\/s11033-014-3516-8 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"83872_CR24","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jamapsychiatry.2016.2575","volume":"73","author":"P Roussos","year":"2016","unstructured":"Roussos, P., Guennewig, B., Kaczorowski, D. C., Barry, G. & Brennand, K. J. Activity-dependent changes in gene expression in schizophrenia human-induced pluripotent stem cell neurons. JAMA Psychiatry 73, 1180\u20131188. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.2575 (2016).","journal-title":"JAMA Psychiatry"},{"key":"83872_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/0471250953.bi1114s51","volume":"51","author":"A Dobin","year":"2015","unstructured":"Dobin, A. & Gingeras, T. R. Mapping RNA-seq Reads with STAR. Curr. Protoc. Bioinform. 51, 11\u201314. https:\/\/doi.org\/10.1002\/0471250953.bi1114s51 (2015).","journal-title":"Curr. Protoc. Bioinform."},{"key":"83872_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323. https:\/\/doi.org\/10.1186\/1471-2105-12-323 (2011).","journal-title":"BMC Bioinform."},{"key":"83872_CR27","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25. https:\/\/doi.org\/10.1186\/gb-2010-11-3-r25 (2010).","journal-title":"Genome Biol."},{"key":"83872_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"83872_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett, D. A., Schneider, J. A., Arvanitakis, Z. & Wilson, R. S. Overview and findings from the religious orders study. Curr. Alzheimer Res. 9, 628\u2013645 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"83872_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnagi.2013.00050","volume":"5","author":"PA Boyle","year":"2013","unstructured":"Boyle, P. A., Yu, L., Wilson, R. S., Schneider, J. A. & Bennett, D. A. Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci. 5, 50. https:\/\/doi.org\/10.3389\/fnagi.2013.00050 (2013).","journal-title":"Front Aging Neurosci."},{"key":"83872_CR31","unstructured":"NIA-Reagan Institute Working Group. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease. Neurobiol. Aging 18, S1\u20132 (1997)."},{"key":"83872_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi, S. et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat. Neurosci. 21, 811\u2013819. https:\/\/doi.org\/10.1038\/s41593-018-0154-9 (2018).","journal-title":"Nat. Neurosci."},{"key":"83872_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried, N. T. et al. A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 4, 60\u201372. https:\/\/doi.org\/10.1016\/j.cels.2016.11.006 (2017).","journal-title":"Cell Syst."},{"key":"83872_CR34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802 (2013).","journal-title":"Nat. Genet."},{"key":"83872_CR35","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: Generalized gene-set analysis of GWAS data. PLoS Comput. Biol 11, e1004219. https:\/\/doi.org\/10.1371\/journal.pcbi.1004219 (2015).","journal-title":"PLoS Comput. Biol"},{"key":"83872_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37\u201353. https:\/\/doi.org\/10.1016\/j.neuron.2015.11.013 (2016).","journal-title":"Neuron"},{"key":"83872_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/288279a0","volume":"288","author":"P Davies","year":"1980","unstructured":"Davies, P., Katzman, R. & Terry, R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 288, 279\u2013280 (1980).","journal-title":"Nature"},{"issue":"Suppl 1","key":"83872_CR38","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","volume":"33","author":"JZ Wang","year":"2013","unstructured":"Wang, J. Z., Xia, Y. Y., Grundke-Iqbal, I. & Iqbal, K. Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheimers Dis. 33(Suppl 1), S123-139. https:\/\/doi.org\/10.3233\/JAD-2012-129031 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"83872_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9806-1","author":"B Chami","year":"2016","unstructured":"Chami, B., Steel, A. J., De La Monte, S. M. & Sutherland, G. T. The rise and fall of insulin signaling in Alzheimer\u2019s disease. Metab. Brain Dis. https:\/\/doi.org\/10.1007\/s11011-016-9806-1 (2016).","journal-title":"Metab. Brain Dis."},{"key":"83872_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou, A. G. & Goate, A. M. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol. Neurodegener. 12, 43. https:\/\/doi.org\/10.1186\/s13024-017-0184-x (2017).","journal-title":"Mol. Neurodegener."},{"key":"83872_CR41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413. https:\/\/doi.org\/10.1038\/s41588-018-0311-9 (2019).","journal-title":"Nat. Genet."},{"key":"83872_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12717","author":"PJ Paasila","year":"2019","unstructured":"Paasila, P. J., Davies, D. S., Kril, J. J., Goldsbury, C. & Sutherland, G. T. The relationship between the morphological subtypes of microglia and Alzheimer\u2019s disease neuropathology. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12717 (2019).","journal-title":"Brain Pathol."},{"issue":"1221","key":"83872_CR43","doi-asserted-by":"publisher","first-page":"e1215","DOI":"10.1016\/j.neurobiolaging.2014.09.003","volume":"36","author":"H Martiskainen","year":"2015","unstructured":"Martiskainen, H. et al. Transcriptomics and mechanistic elucidation of Alzheimer\u2019s disease risk genes in the brain and in vitro models. Neurobiol. Aging 36(1221), e1215-1228. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.003 (2015).","journal-title":"Neurobiol. Aging"},{"key":"83872_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02004-0","author":"P Dourlen","year":"2019","unstructured":"Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J. & Lambert, J. C. The new genetic landscape of Alzheimer\u2019s disease: From amyloid cascade to genetically driven synaptic failure hypothesis?. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02004-0 (2019).","journal-title":"Acta Neuropathol."},{"key":"83872_CR45","doi-asserted-by":"publisher","first-page":"23436","DOI":"10.1074\/jbc.M113.476705","volume":"288","author":"DJ Cipriano","year":"2013","unstructured":"Cipriano, D. J. et al. Processive ATP-driven substrate disassembly by the N-ethylmaleimide-sensitive factor (NSF) molecular machine. J. Biol. Chem. 288, 23436\u201323445. https:\/\/doi.org\/10.1074\/jbc.M113.476705 (2013).","journal-title":"J. Biol. Chem."},{"key":"83872_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41598-017-18597-z","volume":"8","author":"M Borisovska","year":"2018","unstructured":"Borisovska, M. Syntaxins on granules promote docking of granules via interactions with munc18. Sci. Rep. 8, 193. https:\/\/doi.org\/10.1038\/s41598-017-18597-z (2018).","journal-title":"Sci. Rep."},{"key":"83872_CR47","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3233\/JAD-160271","volume":"54","author":"S Musunuri","year":"2016","unstructured":"Musunuri, S. et al. Increased levels of extracellular microvesicle markers and decreased levels of endocytic\/exocytic proteins in the Alzheimer\u2019s disease brain. J. Alzheimers Dis. 54, 1671\u20131686. https:\/\/doi.org\/10.3233\/JAD-160271 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"83872_CR48","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085\u20131092. https:\/\/doi.org\/10.1038\/nn.4328 (2016).","journal-title":"Nat. Neurosci."},{"key":"83872_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1152\/physiolgenomics.00242.2007","volume":"33","author":"WS Liang","year":"2008","unstructured":"Liang, W. S. et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer\u2019s disease: A reference data set. Physiol. Genomics 33, 240\u2013256 (2008).","journal-title":"Physiol. Genomics"},{"key":"83872_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroscience.2018.01.041","volume":"374","author":"D Aguado-Llera","year":"2018","unstructured":"Aguado-Llera, D. et al. The protective effects of IGF-I against beta-Amyloid-related downregulation of hippocampal somatostatinergic system involve activation of akt and protein kinase A. Neuroscience 374, 104\u2013118. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.01.041 (2018).","journal-title":"Neuroscience"},{"key":"83872_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/314090a0","volume":"314","author":"JH Morrison","year":"1985","unstructured":"Morrison, J. H., Rogers, J., Scherr, S., Benoit, R. & Bloom, F. E. Somatostatin immunoreactivity in neuritic plaques of Alzheimer\u2019s patients. Nature 314, 90\u201392 (1985).","journal-title":"Nature"},{"key":"83872_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/314092a0","volume":"314","author":"GW Roberts","year":"1985","unstructured":"Roberts, G. W., Crow, T. J. & Polak, J. M. Location of neuronal tangles in somatostatin neurones in Alzheimer\u2019s disease. Nature 314, 92\u201394 (1985).","journal-title":"Nature"},{"key":"83872_CR53","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.410300415","volume":"30","author":"MM Mouradian","year":"1991","unstructured":"Mouradian, M. M. et al. Somatostatin replacement therapy for Alzheimer dementia. Ann. Neurol. 30, 610\u2013613. https:\/\/doi.org\/10.1002\/ana.410300415 (1991).","journal-title":"Ann. Neurol."},{"key":"83872_CR54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/FBP.0000000000000300","volume":"28","author":"V Douchamps","year":"2017","unstructured":"Douchamps, V. & Mathis, C. A second wind for the cholinergic system in Alzheimer\u2019s therapy. Behav. Pharmacol. 28, 112\u2013123. https:\/\/doi.org\/10.1097\/FBP.0000000000000300 (2017).","journal-title":"Behav. Pharmacol."},{"key":"83872_CR55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12035-014-9011-3","volume":"53","author":"Z Bai","year":"2016","unstructured":"Bai, Z. et al. AlzBase: An integrative database for gene dysregulation in Alzheimer\u2019s disease. Mol. Neurobiol. 53, 310\u2013319. https:\/\/doi.org\/10.1007\/s12035-014-9011-3 (2016).","journal-title":"Mol. Neurobiol."},{"key":"83872_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dneu.20853","volume":"71","author":"B Rudy","year":"2011","unstructured":"Rudy, B., Fishell, G., Lee, S. & Hjerling-Leffler, J. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev. Neurobiol. 71, 45\u201361. https:\/\/doi.org\/10.1002\/dneu.20853 (2011).","journal-title":"Dev. Neurobiol."},{"key":"83872_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.050","author":"C Miao","year":"2017","unstructured":"Miao, C., Cao, Q., Moser, M. & Moser, E. I. Parvalbumin and somatostatin interneurons control different space-coding networks in the medial entorhinal cortex. Cell https:\/\/doi.org\/10.1016\/j.cell.2017.08.050 (2017).","journal-title":"Cell"},{"key":"83872_CR58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nn.4257","volume":"19","author":"W Zhang","year":"2016","unstructured":"Zhang, W. et al. Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders. Nat. Neurosci. 19, 557\u2013559. https:\/\/doi.org\/10.1038\/nn.4257 (2016).","journal-title":"Nat. Neurosci."},{"key":"83872_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuron.2012.11.004","volume":"77","author":"H Xu","year":"2013","unstructured":"Xu, H., Jeong, H. Y., Tremblay, R. & Rudy, B. Neocortical somatostatin-expressing GABAergic interneurons disinhibit the thalamorecipient layer 4. Neuron 77, 155\u2013167. https:\/\/doi.org\/10.1016\/j.neuron.2012.11.004 (2013).","journal-title":"Neuron"},{"key":"83872_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T Gomez-Isla","year":"1997","unstructured":"Gomez-Isla, T. et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann. Neurol. 41, 17\u201324 (1997).","journal-title":"Ann. Neurol."},{"key":"83872_CR61","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2008.03.043","volume":"1213","author":"JA van de Nes","year":"2008","unstructured":"van de Nes, J. A., Nafe, R. & Schlote, W. Non-tau based neuronal degeneration in Alzheimer\u2019s disease\u2014An immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. Brain Res. 1213, 152\u2013165. https:\/\/doi.org\/10.1016\/j.brainres.2008.03.043 (2008).","journal-title":"Brain Res."},{"key":"83872_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-016-1647-9","volume":"133","author":"A Ramos-Miguel","year":"2017","unstructured":"Ramos-Miguel, A. et al. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer\u2019s disease. Acta Neuropathol. 133, 395\u2013407. https:\/\/doi.org\/10.1007\/s00401-016-1647-9 (2017).","journal-title":"Acta Neuropathol."},{"key":"83872_CR63","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1261\/rna.2658311","volume":"17","author":"RC Pink","year":"2011","unstructured":"Pink, R. C. et al. Pseudogenes: Pseudo-functional or key regulators in health and disease?. RNA 17, 792\u2013798. https:\/\/doi.org\/10.1261\/rna.2658311 (2011).","journal-title":"RNA"},{"key":"83872_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-018-0803-3","volume":"17","author":"N Haddadi","year":"2018","unstructured":"Haddadi, N. et al. PTEN\/PTENP1: \u2018Regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy. Mol. Cancer 17, 37. https:\/\/doi.org\/10.1186\/s12943-018-0803-3 (2018).","journal-title":"Mol. Cancer"},{"key":"83872_CR65","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1073\/pnas.1310249110","volume":"110","author":"B Bai","year":"2013","unstructured":"Bai, B. et al. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U S A 110, 16562\u201316567. https:\/\/doi.org\/10.1073\/pnas.1310249110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"83872_CR66","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","volume":"29","author":"YC Hsieh","year":"2019","unstructured":"Hsieh, Y. C. et al. Tau-mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer\u2019s disease. Cell Rep. 29, 301-316e310. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.104 (2019).","journal-title":"Cell Rep."},{"key":"83872_CR67","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.28401","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Somatostatin binds to the human amyloid beta peptide and favors the formation of distinct oligomers. Elife https:\/\/doi.org\/10.7554\/eLife.28401 (2017).","journal-title":"Elife"},{"key":"83872_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336896.2017.1405207","volume":"12","author":"M Solarski","year":"2018","unstructured":"Solarski, M., Wang, H., Wille, H. & Schmitt-Ulms, G. Somatostatin in Alzheimer\u2019s disease: A new role for an old player. Prion 12, 1\u20138. https:\/\/doi.org\/10.1080\/19336896.2017.1405207 (2018).","journal-title":"Prion"},{"key":"83872_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.05.009","author":"H Patel","year":"2019","unstructured":"Patel, H. et al. Transcriptomic analysis of probable asymptomatic and symptomaticAlzheimer brains. Brain Behav. Immun. https:\/\/doi.org\/10.1016\/j.bbi.2019.05.009 (2019).","journal-title":"Brain Behav. Immun."}],"updated-by":[{"DOI":"10.1038\/s41598-023-36807-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000}},{"DOI":"10.1038\/s41598-021-97076-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83872-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83872-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83872-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:06:54Z","timestamp":1687255614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83872-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83872"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83872-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"15 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-36807-9","URL":"https:\/\/doi.org\/10.1038\/s41598-023-36807-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-97076-y","URL":"https:\/\/doi.org\/10.1038\/s41598-021-97076-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing interests. B.G. is a director of Pacific Analytics PTY LTD & SMRTR PTY LTD, Australia; a founding member of the International Cerebral Palsy Genetics Consortium and a member of the Australian Genomics Health Alliance.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4865"}}